Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With PTR

Platelet Transfusion Refractoriness Clinical Trial

Official title:
Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With Platelet Refractoriness

Status Recruiting

Clinical Trial Summary

The purpose of this study is to improve the platelet level of PTR patients; Prevent and improve bleeding; Help patients to successfully through the bone marrow suppression period after chemotherapy; Reduce the overall rate of PTR and allo-immunity; Saving platelet resources and reducing blood burden.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Platelet Transfusion Refractoriness

Clinical Trial Details

NCT number	NCT05761457
Study type	Interventional
Source	The First Affiliated Hospital of Soochow University
Contact	Yue Han, PhD,MD
Phone	13901551669
Email	hanyue@suda.edu.cn
Status	Recruiting
Phase	N/A
Start date	March 1, 2023
Completion date	January 10, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02858323` - Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion
Recruiting	`NCT06254560` - Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness	Phase 2
Recruiting	`NCT05399693` - Platelet Transfusion Refractoriness
Recruiting	`NCT04846439` - Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL	Phase 1/Phase 2
Recruiting	`NCT05832216` - Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients With Aplastic Anemia	Phase 1